Medicare plans can now cover Wegovy for patients at risk of heart disease
This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.
A Cone Health cardiologist is urging more women to take part in clinical heart disease trials to help reduce death rates.